ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "quality of care"

  • Abstract Number: 0724 • ACR Convergence 2022

    Development of a Global Strategy to Strengthen Health Systems for Prevention and Management of Musculoskeletal Health

    Andrew Briggs1, Anthony Woolf2, Carmen Huckel Schneider3, Helen Slater4, Joanne Jordan5, Sakira Parambath6, James Young7, Saurab Sharma8, Deborah Kopansky-Giles7, Swatee Mishra9, Kristina Akesson10, Karsten Dreinhoefer11, Neil Betteridge12 and Lyn March13, 1Curtin University, Perth, Western Australia, Australia, 2Bone and Joint Resaerch Group, Truro, United Kingdom, 3Menzies Centre for Health Policy and Economic, Faculty of Medicine and Health, University of Sydney, Sydney, Australia, 4Curtin School of Allied Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia, 5HealthSense (Aust) Pty, Ltd, Melbourne, Australia, 6Menzies Centre for Health Policy and Economics, Faculty of Medicine and Health, University of Sydney, Sydney, Australia, 7Department of Research, Canadian Memorial Chiropractic College, Toronto, ON, Canada, 8Department of Physiotherapy, Kathmandu University School of Medical Sciences, Kavre, Nepal, 9Sydney Musculoskeletal, Bone and Joint Health Alliance. Institute of Bone and Joint Research, Kolling Institute, Faculty of Medicine and Health, University of Sydney, Sydney, Australia, 10Department of Clinical Sciences Malmo, Clinical and Molecular Osteoporosis Research Unit, Lund University, Malmö, Sweden, 11Medical Park Berlin Humboldtmühle, Berlin, Germany, 12Neil Betteridge Associates, London, United Kingdom, 13Sydney Medical School, Institute of Bone and Joint Research, and Department of Rheumatology, Royal North Shore Hospital, St. Leonards, Australia

    Background/Purpose: The need to control the burden of musculoskeletal (MSK) conditions is not reflected in policies and practices across the globe. This study aims to…
  • Abstract Number: 1280 • ACR Convergence 2022

    Patients with Systemic Lupus Erythematosus Perceive the Quality of Care They Receive to Be Suboptimal

    Sidha Sreedharan1, Geoffrey Littlejohn2, Russell Buchanan3, Mandana Nikpour4, Eric Morand5, Alberta Hoi6 and Vera Golder7, 1Monash Health, North Melbourne, Australia, 2OPAL Rheumatology Ltd, Melbourne, Australia, 3Austin Health, Heidelberg, Australia, 4The University of Melbourne at St. Vincent's Hospital Melbourne, Melbourne, Australia, 5Monash University, Victoria; Department of Rheumatology, Monash Health, Melbourne, Australia, 6Monash Health, Melbourne, Australia, 7Monash University, Clayton, Australia

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune disease associated with frequent healthcare interactions. The Chronic Care Model is a widely accepted framework…
  • Abstract Number: PP15 • ACR Convergence 2022

    Coordination of Care by a Healthcare Team for Unexpected and Unusual Side Effects Occurring During a Global Pandemic

    Laura Genoves, Arthritis Foundation, Bainbridge Island, WA

    Background/Purpose: I am a patient who lives with moderate to severe RA. My quality of life is dependent on medications such as a biologic, DMARDs…
  • Abstract Number: 0726 • ACR Convergence 2022

    Optimizing Laboratory Medication Safety Monitoring in Patients with JIA to Advance Value-based Care

    Julia Harris1, Leslie Favier2, Emily Fox3, Michael Holland3, Cara Hoffart3, Maria Ibarra3, Jordan Jones3, Luke Harris1 and Ashley Cooper3, 1Children's Mercy Kansas City, Overland Park, KS, 2Children's Mercy Kansas City, Leawood, KS, 3Children's Mercy Kansas City, Kansas City, MO

    Background/Purpose: Most children with juvenile idiopathic arthritis (JIA) are treated with medications that require medication safety monitoring labs. Recommended laboratory testing includes a creatinine level.…
  • Abstract Number: 1281 • ACR Convergence 2022

    Less Than Half of Cryoglobulin Tests Ordered at a Tertiary Hospital Network Are Successfully Completed: An Opportunity for Improvement

    Joo Young (Esther) Lee1, Alexis Baass2, Sasha Bernatsky3, Evelyne Vinet2 and Arielle Mendel2, 1McGill University, Montréal, QC, Canada, 2McGill University Health Centre, Montréal, QC, Canada, 3Research Institute of the McGill University Health Centre, Montréal, QC, Canada

    Background/Purpose: Cryoglobulin detection is essential for the diagnosis of cryoglobulinemic vasculitis, a condition leading to high healthcare use, organ damage, and even death. Successful cryoglobulin…
  • Abstract Number: PP23 • ACR Convergence 2022

    The Journey to Collaborative Care and Patient-Centric Educational Opportunities for a Scleroderma Patient

    Amy Gietzen and Hannah Bowen, The Ann Steffens Scleroderma Foundation, Albany, NY

    Background/Purpose: In 2001 I started to experience forearm, elbow, and wrist pain. My fingers were constantly swollen, and sensitive. After 6 months of living in…
  • Abstract Number: 0727 • ACR Convergence 2022

    Primary Prevention of Fractures in Osteoporotic Patients in a Southern California Academic Health System

    Eugene Looi1, Gergana Mishkova1 and Christina Downey2, 1Loma Linda University, Loma Linda, CA, 2Loma Linda University Medical Center, Redlands, CA

    Background/Purpose: Osteoporosis (OSP) is common, carries high morbidity, significant cost and remains underrecognized and undertreated by health care providers (1). At a university-based academic health…
  • Abstract Number: 1283 • ACR Convergence 2022

    Frequency of Checking Creatine Kinase in Patients on Statins with Elevated Transaminase for Early Detection of Statin Induced Myopathy

    ANJALI NIDHAAN, Andrei Hastings, david gonzalez, rajshri joshi, nathan gilbert and carolyn o'connor, Cleveland Clinic Akron General, Akron, OH

    Background/Purpose: Some of the most commonly reported side effects of statins (widely used lipid lowering agents) are muscle injury (incidence ranging from 0.1-20% based on…
  • Abstract Number: 0770 • ACR Convergence 2022

    Immune Related Adverse Events in Checkpoint Inhibitor Treated Cancer Patients Increased in Patients with Underlying Autoimmune Disease and Positive Autoantibodies

    Amarah Baluch1, Katerina Warda2, Taylor Middleton2, Kiersten Kennedy2, Andras Perl3 and Jihad Ben Gabr1, 1SUNY Upstate Medical University, Syracuse, NY, 2SUNY Upstate Medical Unviersity, Syracuse, NY, 3SUNY, Syracuse, NY

    Background/Purpose: Immune check point inhibitors (ICIs) boost the patient's immune system by blocking intrinsic down-regulators of immunity by signaling through cytotoxic T-lymphocyte antigen 4 (CTLA-4),…
  • Abstract Number: 1288 • ACR Convergence 2022

    How Often Do We Provide Relevant and Patient Centric Discharge Instructions in Rheumatology? A Single Academic Center Clinic Experience

    Dijo Joseph1, Asha Asthana2, Sobia Hassan3 and Meenakshi Jolly3, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center Department of Internal Medicine, Chicago, IL, 3Rush University, Chicago, IL

    Background/Purpose: Post-visit discharge instructions (DCI) are an important supplement to the patient visit that serves to reinforce a patient's understanding of their diagnosis, medications and…
  • Abstract Number: 0056 • ACR Convergence 2022

    Pilot Study to Implement the Type 1 & 2 SLE Model in an Academic Rheumatology Clinic

    Amanda Eudy1, Jennifer Rogers2, Kai Sun3, Rebecca Sadun3, David Pisetsky4, Mithu Maheswaranathan2, Jayanth Doss3, Lisa Criscione-Schreiber5 and Megan Clowse3, 1Duke University, Raleigh, NC, 2Duke, Durham, NC, 3Duke University, Durham, NC, 4Duke University Medical Center, Durham, NC, 5Duke University School of Medicine, Durham, NC

    Background/Purpose: The Type 1 & 2 SLE Model was developed to better explain the signs, symptoms, and management goals of SLE to patients. We assembled…
  • Abstract Number: 0860 • ACR Convergence 2022

    Characteristics of Transitioning JIA Patients: Who Is Arriving on the Adult Rheumatologists’ Doorsteps?

    Teresa Semalulu1, KAREN BEATTIE1, Roberta Berard2, Jaime Guzman3 and Michelle Batthish1, 1McMaster University, Hamilton, ON, Canada, 2London Health Sciences Centre, London, ON, Canada, 3University of British Columbia and BC Children's Hospital, Vancouver, BC, Canada

    Background/Purpose: Patients with JIA are at an increased risk of loss to follow-up, morbidity and mortality as they transition from pediatric to adult care. Thus,…
  • Abstract Number: 1291 • ACR Convergence 2022

    Development and Pilot Implementation of a Predictive Model to Identify Visits Appropriate for Telehealth

    david leverenz1, Mary Solomon1, Nicoleta Economau-Zavlanos1, Bhargav Srinivas Adagarla2, Theresa Coles1, Isaac Smith3, Robert Overton1, Catherine Howe3, Jayanth Doss4, Ricardo Henao1 and Megan Clowse4, 1Duke University School of Medicine, Durham, NC, 2Duke Clinical Research Institute, Durham, NC, 3Duke University Hospital, Durham, NC, 4Duke University, Durham, NC

    Background/Purpose: Since January 2021, providers in our practice have used the Encounter Appropriateness Score for You (EASY) to document their perception of the appropriateness of…
  • Abstract Number: 0057 • ACR Convergence 2022

    Accelerating AxSpA Diagnosis: Exploring At-home Self-sampling, Symptom Checkers, Medical Student-visits and Asynchronous Report-based Assessment

    Hannah Labinsky1, Sophie von Rohr2, Maria Gabriella Raimondo3, Ekaterina Vogt4, Britta Horstmann2, Isabel Gehring5, Jessica Rojas-Restrepo5, Fabian Proft6, Felix Mühlensiepen7, Daniela Bohr2, Georg Schett8, Andreas Ramming3 and Johannes Knitza3, 1Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 2Department of Internal Medicine 3, Rheumatology & Immunology, Friedrich-Alexander-University (FAU) Erlangen-Nurnberg and University Hospital Erlangen, Erlangen, Germany, 3Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 4Thermo Fisher Scientific, Freiburg, Germany, 5Thermo Fisher Scientific, Freiburg, 6Department of Gastroenterology, Infectious Diseases and Rheumatology, Charité – Universitätsmedizin Berlin, Berlin, Germany, 7Center for Health Services Research, Brandenburg Medical School Theodor Fontane, Rüdersdorf, 8Universitätsklinikum Erlangen, Erlangen, Germany

    Background/Purpose: The growing shortage of rheumatologists threatens adequate rheumatological care. The diagnostic delay for axial spondyloarthritis (axSpA) is particularly long, ranging between 3 to 11…
  • Abstract Number: 0944 • ACR Convergence 2022

    Inconsistent Family Planning Documentation in Women with Interstitial Pneumonia with Autoimmune Features (IPAF)

    Elena Joerns1, Brooke Mills2, Una Makris3, Traci Adams1 and Bonnie Bermas1, 1UT Southwestern, Dallas, TX, 2UT Southwestern Medical Center, Fort Worth, TX, 3UT Southwestern Medical Center and Dallas VA, Dallas, TX

    Background/Purpose: Family planning discussions improve pregnancy outcomes in women with interstitial lung disease (ILD). Women with interstitial pneumonia with autoimmune features (IPAF), a subset of…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology